Bharat Parenterals Ltd

Bharat Parenterals Ltd is a pharmaceutical company founded in 1992 with the mission of Harnessing Science For Life. Under the leadership of Chairman Mr. Ramesh Desai and Mr. Bharat R. Desai, the company has experienced significant growth, offering a portfolio of over 800 products in 20 therapeutical categories.

The company's WHO-GMP accredited manufacturing unit serves as a 2 Star Export House, providing products to 60+ clients in 15+ countries. What sets Bharat Parenterals Ltd apart is its DSIR Approved Formulation R&D Centre for Excellence, focusing on the development of innovative formulations.

Bharat Parenterals Ltd operates 3 dedicated manufacturing units for General, Cephalosporin, and B-Lactam drug formulations. As a publicly traded company on the BSE, it serves as the parent company to 3 growing organizations:

Varenyam Healthcare Private Limited, the domestic marketing arm, markets formulations in niche therapy areas. Varenyam Bio-Lifesciences is a manufacturing unit dedicated to niche formulations, with plans for accreditation by EU-GMP and other region's bodies. Additionally, Innoxel Lifesciences Limited is a US FDA manufacturing unit pioneering patient-centric treatment solutions in India.

Overall, Bharat Parenterals Ltd's focus on innovation, market expansion, and organic growth positions it as a promising investment opportunity in the biotechnology and pharmaceutical industries.